The
transfer of peptide ions from solution into the gas phase by
electrospray ionization (ESI) is an integral component of mass spectrometry
(MS)-based proteomics. The mechanisms whereby gaseous peptide ions
are released from charged ESI nanodroplets remain unclear. This is
in contrast to intact protein ESI, which has been the focus of detailed
investigations using molecular dynamics (MD) simulations and other
methods. Under acidic liquid chromatography/MS conditions, many peptides
carry a solution charge of 3+ or 2+. Because of this pre-existing
charge and their relatively small size, prevailing views suggest that
peptides follow the ion evaporation mechanism (IEM). The IEM entails
analyte ejection from ESI droplets, driven by electrostatic repulsion
between the analyte and droplet. Surprisingly, recent peptide MD investigations
reported a different behavior, that is, the release of peptide ions via droplet evaporation to dryness which represents the
hallmark of the charged residue mechanism (CRM). Here, we resolved
this conundrum by performing MD simulations on a common model peptide
(bradykinin) in Rayleigh-charged aqueous droplets. The primary focus
was on pH 2 conditions (bradykinin solution charge = 3+), but we also
verified that our MD strategy captured pH-dependent charge state shifts
seen in ESI-MS experiments. In agreement with earlier simulations,
we found that droplets with initial radii of 1.5–3 nm predominantly
release peptide ions via the CRM. In contrast, somewhat
larger radii (4–5 nm) favor IEM behavior. It appears that these
are the first MD data to unequivocally demonstrate the viability of
peptide IEM events. Electrostatic arguments can account for the observed
droplet size dependence. In summary, both CRM and IEM can be operative
in peptide ESI-MS. The prevalence of one over the other mechanism
depends on the droplet size distribution in the ESI plume.